[go: up one dir, main page]

GB0303532D0 - Particles for the delivery of agents to the body - Google Patents

Particles for the delivery of agents to the body

Info

Publication number
GB0303532D0
GB0303532D0 GB0303532A GB0303532A GB0303532D0 GB 0303532 D0 GB0303532 D0 GB 0303532D0 GB 0303532 A GB0303532 A GB 0303532A GB 0303532 A GB0303532 A GB 0303532A GB 0303532 D0 GB0303532 D0 GB 0303532D0
Authority
GB
United Kingdom
Prior art keywords
delivery
agents
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0303532A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Upperton Ltd
Original Assignee
Upperton Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upperton Ltd filed Critical Upperton Ltd
Priority to GB0303532A priority Critical patent/GB0303532D0/en
Publication of GB0303532D0 publication Critical patent/GB0303532D0/en
Priority to CN200480006063A priority patent/CN100591361C/en
Priority to CA002516409A priority patent/CA2516409A1/en
Priority to AT04711636T priority patent/ATE411819T1/en
Priority to AU2004212263A priority patent/AU2004212263B2/en
Priority to KR1020057015055A priority patent/KR20050121673A/en
Priority to PCT/GB2004/000582 priority patent/WO2004071536A1/en
Priority to ES04711636T priority patent/ES2316961T3/en
Priority to EP04711636A priority patent/EP1605979B1/en
Priority to DE602004017290T priority patent/DE602004017290D1/en
Priority to US10/545,969 priority patent/US20060171892A1/en
Priority to JP2006502275A priority patent/JP2006518727A/en
Priority to US12/929,356 priority patent/US20110142762A1/en
Ceased legal-status Critical Current

Links

GB0303532A 2003-02-17 2003-02-17 Particles for the delivery of agents to the body Ceased GB0303532D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GB0303532A GB0303532D0 (en) 2003-02-17 2003-02-17 Particles for the delivery of agents to the body
JP2006502275A JP2006518727A (en) 2003-02-17 2004-02-17 Conjugate for medical imaging comprising a carrier, a targeting moiety, and a contrast agent
PCT/GB2004/000582 WO2004071536A1 (en) 2003-02-17 2004-02-17 Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent
CA002516409A CA2516409A1 (en) 2003-02-17 2004-02-17 Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent
AT04711636T ATE411819T1 (en) 2003-02-17 2004-02-17 CONJUGATES FOR MEDICAL IMAGING COMPRISING CARRIERS, TARGETING MOTIONS AND CONTRAST AGENTS
AU2004212263A AU2004212263B2 (en) 2003-02-17 2004-02-17 Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent
KR1020057015055A KR20050121673A (en) 2003-02-17 2004-02-17 Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent
CN200480006063A CN100591361C (en) 2003-02-17 2004-02-17 Conjugates for medical imaging comprising carrier, targeting moiety and contrast agent
ES04711636T ES2316961T3 (en) 2003-02-17 2004-02-17 CONJUGATED FOR THE FORMATION OF MEDICAL IMAGES THAT INCLUDE CARRIER, OTHER GUIDANCE AND A CONTRACTING AGENT.
EP04711636A EP1605979B1 (en) 2003-02-17 2004-02-17 Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent
DE602004017290T DE602004017290D1 (en) 2003-02-17 2004-02-17 CONJUGATES FOR MEDICAL FIGURES INCLUDING CARRIER, TARGETING UNITS AND CONTRAST
US10/545,969 US20060171892A1 (en) 2003-02-17 2004-02-17 Conjugates for medical imaging comprising carrier, targetting moiety and a contrast agent
US12/929,356 US20110142762A1 (en) 2003-02-17 2011-01-19 Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0303532A GB0303532D0 (en) 2003-02-17 2003-02-17 Particles for the delivery of agents to the body

Publications (1)

Publication Number Publication Date
GB0303532D0 true GB0303532D0 (en) 2003-03-19

Family

ID=9953098

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0303532A Ceased GB0303532D0 (en) 2003-02-17 2003-02-17 Particles for the delivery of agents to the body

Country Status (2)

Country Link
CN (1) CN100591361C (en)
GB (1) GB0303532D0 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101347625B (en) * 2007-07-20 2010-07-28 上海交通大学医学院附属瑞金医院 Nuclear magnetic resonance thrombus targeting contrast agent and preparation method thereof
CN104072765B (en) * 2014-07-09 2017-07-28 中国科学院长春应用化学研究所 Modified polyethyleneimine and preparation method thereof, drug gene carrier system and preparation method thereof
CN118767173B (en) * 2024-06-14 2025-09-02 中国科学技术大学 Probe for in vivo imaging and its preparation method and application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990003401A1 (en) * 1988-09-30 1990-04-05 Neorx Corporation Targeting substance-diagnostic/therapeutic agent conjugates having schiff base linkages

Also Published As

Publication number Publication date
CN100591361C (en) 2010-02-24
CN1761489A (en) 2006-04-19

Similar Documents

Publication Publication Date Title
IL173866A0 (en) Sustained release dosage forms of ziprasidone
SI1658055T1 (en) Form of administration secured against misuse
IL186616A (en) Spiro-oxindole compounds and their use as therapeutic agents
AU2003285091A8 (en) Interferon antagonists useful for the treatment of interferon related diseases
AU2003298749A8 (en) Buoyant polymer particles delivering therapeutic agents
GB0324761D0 (en) Use of compounds in therapy
PL1626913T3 (en) Use of ciclesonide for maintaining fine particle fraction of formoterol
AU2003301405A8 (en) Prepolymeric materials for site specific delivery to the body
EP1680145A4 (en) Methods and compositions for the treatment of neurological disease
EP1699435A4 (en) Particles
GB0324147D0 (en) Functionilisation of particles
IL183893A0 (en) Pharmaceutical compositions for the treatment of cellulite
EP1757282A4 (en) The use of kauranes compounds in the manufacture of medicament
EP1617847A4 (en) Methods for the controlled delivery of pharmacologically active compounds
GB0609785D0 (en) Modular system of electronic assemblies worn close to the body
GB0303532D0 (en) Particles for the delivery of agents to the body
TWI365187B (en) 7-azaindoles and the use thereof as therapeutic agents
AU2003270202A8 (en) Pharmaceutical compositions useful for the treatment of cancers
GB0303533D0 (en) Delivery of agents to the body
GB0304524D0 (en) Therapeutic agents
GB0312844D0 (en) Use of compounds in medicine
GB0317128D0 (en) Use of antitumoral compounds
TW574879U (en) Structure of table body
PL376773A1 (en) Clothing for partial protection of the body against biological agents
HU0400429D0 (en) Body spray

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)